Novopharm v. Canada (Minister of Health), 2010 FC 156, on behalf of Pfizer Canada Inc.
Successfully argued for costs following withdrawal of application while decision on merits under reserve.
See Novopharm v. Canada (Minister of Health), 2010 FC 156
